Properties of plasminogen activators formed by neoplastic human cell cultures
about
Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cellsDirect fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.Adjuvant treatment of ovarian carcinoma with tranexamic acidPlasminogen activators in normal tissue and carcinomas of the human oesophagus and stomachGeneration of macrophage migration inhibitory activity by plasminogen activatorsProtease effects on specific growth properties of normal and transformed baby hamster kidney cellsCorrelated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cellsPlasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40.XH1--a new cervical carcinoma cell line and xenograft model of tumour invasion, 'metastasis' and regression.Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours.Reversible suppression of malignancy and differentiation of melanoma cellsProduction of plasminogen activator by established cell lines of mouse origin.Patterns of plasminogen activator production in cultured normal embryonic cells.Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinomaTumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe.Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cellsProtease-activated "prodrugs" for cancer chemotherapy.Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.Sensitive assay for plasminogen activator of transformed cells.Secretory function of mononuclear phagocytes: a review.Synthesis and secretion of alpha-2-macroglobulin by cultured adherent lung cells. Comparison with cell strains derived from other tissues.Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cellsIsolation of cDNA sequences coding for a part of human tissue plasminogen activator.Hemostatic defects in cancer patients.Immunological analysis of plasminogen activators from normal and transformed hamster cells. Evidence that the plasminogen activators produced by SV40 virus-transformed hamster embryo cells and normal hamster lung cells are antigenically identical.Plasminogen activation: biochemistry, physiology, and therapeutics.In vitro studies on the mode of action of the phorbol esters, potent tumor promoters, part 2.Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.Serine enzymes released by cultured neoplastic cellsParacrine control of differentiation in the alveolar carcinoma, A549, by human foetal lung fibroblasts.Interrelationship between differentiation and malignancy-associated properties in glioma.Cytolytic effects of the complement cleavage product, C3a.Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.The glycoprotein nature of human plasminogen activators.Purification and characterization of a melanoma cell plasminogen activator.Production of tissue plasminogen activator (tPA) in two and three dimensionally growing cultures of Bowes melanoma cells.Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas
P2860
Q30494593-75188557-5A4C-4B62-9BD6-338388EAC347Q33961219-5289E669-725A-4FE5-ADEC-29DD3C5721C9Q34302623-27D4D16B-7203-45C2-B908-78CEE12DF4B9Q34376257-E7C57BCE-93E2-47BF-B0E3-F43788298326Q35019413-DE8C57D4-1CFD-4D12-98E0-A682886B67E6Q35036167-5042C9A1-AEE6-458B-AD4D-3AE3450DCC8EQ35065779-07DFD701-E30B-4732-847D-3B7C4112F40DQ35119604-FFD257F7-6AB1-4D77-906D-AAF2C58CC525Q35993873-EBD306BA-F29A-40C1-843A-427072DA0D97Q36046804-8AA230B6-7D2B-48BC-9978-B59B71E8CB63Q36077431-7CA5697C-4472-4D6E-91A9-71F3DF82E660Q36198561-0B898880-5EAC-40C4-84BA-BC465332D85EQ36203956-5F295BCE-6DE2-4509-87A0-D71C29FCD146Q36210147-6E37F51B-E715-4A83-B105-BBF6294CFC3BQ36210862-BABEEB30-4DE9-43F1-9EF5-19C5EE5D661BQ36249478-90E28A19-F4B7-420A-9190-E3A46E94C893Q36299757-BF5C5D13-5406-442A-AC98-3145CFC194C5Q36358980-C2A5D84E-8D8D-46F4-A1BA-0D93BCC0B251Q36364891-6AB241D0-4D93-4AC2-9A9A-61A11800E389Q36384769-BE23DBC3-3988-4F7C-BE35-BD08D81CBF96Q36396013-D100E8B1-260D-45F1-946F-E8327E590566Q36932427-21C94F4F-5623-4079-A5F1-4E5FABC71619Q37048112-3BF5D067-0290-4686-9FA5-57D55579378AQ37311345-027FDFEF-6B09-429A-B2E1-0033F451B572Q37601324-A1831C4E-C7BE-45CB-BAEA-B13146430976Q39127942-20E52C57-6F37-4C84-A292-AC0A9262FD22Q39332117-34CEC18A-8514-430D-99BA-812DE59B7E29Q39489577-5E4371A2-0039-4A85-94F5-3D7590F0C5C1Q40309436-68758572-EC1D-4439-8FC0-3313A4271ACBQ41450847-ACDBE28A-DEEB-46D0-9599-B75A0FA8AC87Q41464630-AA4DE5BF-AE96-4B25-859C-46F1FD3556DCQ41873749-B05F84CB-8F43-4F1C-A089-4F212DA0FD74Q42372186-937C0D71-A6A4-46E5-8CDE-40AB3F389F76Q42374654-D94F9782-DFE7-4C55-BCC0-91FB7136099DQ42578367-BA1BBA28-FF6A-4FDE-A523-7A616BCF87A8Q42849229-9175D344-E208-48DE-A9CB-733BABCA19A2Q43754496-34D02A7E-2004-4396-A36D-CCBB006F7FA1Q44032827-D57B8156-833A-4D2D-855C-2D1FE30706D5Q47863368-0FE4810C-8936-494C-B2D9-309FC0429D3DQ59085627-B7FEAC11-7A69-4391-90C0-13FB794C5308
P2860
Properties of plasminogen activators formed by neoplastic human cell cultures
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Properties of plasminogen activators formed by neoplastic human cell cultures
@ast
Properties of plasminogen activators formed by neoplastic human cell cultures
@en
type
label
Properties of plasminogen activators formed by neoplastic human cell cultures
@ast
Properties of plasminogen activators formed by neoplastic human cell cultures
@en
prefLabel
Properties of plasminogen activators formed by neoplastic human cell cultures
@ast
Properties of plasminogen activators formed by neoplastic human cell cultures
@en
P2093
P2860
P356
P1476
Properties of plasminogen activators formed by neoplastic human cell cultures
@en
P2093
P2860
P304
P356
10.1084/JEM.139.5.1317
P407
P577
1974-05-01T00:00:00Z